NEW YORK, June 22 - Rubicon Genomics has appointed Thomas Collet, a former health care venture capitalist, to lead the company as president and chief executive officer, the company said Friday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.